Lycopene in Preventing Prostate Cancer in Healthy Participants

Completed · Phase 1

Conditions studied: Prostate Cancer

In brief

RATIONALE: Chemoprevention therapy is the use of certain substances to try to prevent the development or recurrence of cancer. The dietary supplement lycopene may prevent the development of prostate cancer. PURPOSE: This phase I trial is studying the side effects and best dose of lycopene in preventing prostate cancer in healthy participants.

Key facts

Study ID

NCT00093561

Run by

University of Illinois at Chicago

Starts

2004-08-01

Expected to finish

2006-02-01

Last updated by the study team

2013-06-26

Who can join

Age: 18 and older, up to 45. Sex: male. Healthy volunteers: accepted.

Where it is running

• University of Illinois at Chicago Cancer Center — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.